Position in EQ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$317,466
+$317,466 QoQ
Shares Held
158,733
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EQ Over Time
Shares Held
Position Value (USD)
Derivatives in EQ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$62,400
PutShares
31,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. EQ ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in EQ
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,400 | 31,200 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $317,466 | 158,733 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $43,400 | 28,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $123,380 | 79,600 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $25,740 | 18,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $122,346 | 85,557 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $41,825 | 130,705 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $39 | 100 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $21,703 | 55,649 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $5,148 | 13,200 | Call | Defined | 2025-05-15 | |
| 2024-03-31 | $23,100 | 10,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $706 | 306 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $462 | 200 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $4,248 | 5,900 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $45,359 | 62,999 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $148 | 200 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $6,586 | 8,900 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $34,767 | 46,983 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,989 | 46,652 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $900 | 1,200 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $15,975 | 21,300 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $12,842 | 17,593 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $15,549 | 21,300 | Call | Defined | 2023-05-15 | |
| 2022-12-31 | $39,326 | 37,100 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $6,254 | 5,900 | Put | Defined | 2023-02-14 | |
| 2022-12-31 | $54,055 | 50,996 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $126,762 | 57,100 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $84,138 | 37,900 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $32,028 | 15,700 | Call | Defined | 2022-08-15 | |
| 2021-12-31 | $58,955 | 15,638 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $47,125 | 12,500 | Call | Defined | 2022-02-14 | |
| 2021-09-30 | $74,399 | 10,909 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $152,766 | 21,366 | Shares | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||